Astex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013453)
◆英語タイトル:Astex Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013453
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:39
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myelodysplastic syndromes), is marketed by Otsuka in the US and by Janssen in the rest of the world. It established a strong pipeline of small molecule and molecularly-targeted drugs for treating hematologic malignancies, solid tumors and myelodysplastic syndromes. Astex Pharmaceuticals is also advancing several of its compounds into clinical trials in collaboration with Novartis, AstraZeneca, GSK and Janssen. Astex Pharmaceuticals is a subsidiary of Otsuka Pharmaceutical Co Ltd and is headquartered in Pleasanton, California, the US.

Astex Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Astex Pharma Enters into Agreement with Genentech 11
Astex Pharma, Cancer Research Technology And Newcastle University Enter Into Drug Discovery Agreement 12
Astex Pharma, Cancer Research Technology And Institute of Cancer Research Enter Into Epigenetic Drug Discovery Agreement 14
Proteros Biostructures Enters Into Drug Discovery Agreement With SuperGen 16
Equity Offering 17
Astex Pharma Files Registration Statement For Public Offering Of Securities For US$200 Million 17
Asset Transactions 19
Tolero Pharma Acquires Drug Development Assets From Astex Pharma 19
Acquisition 21
Otsuka Pharma Completes Acquisition Of Astex Pharma For US$886 Million 21
Gimv Sells Stake In Astex Therapeutics 23
SuperGen Completes Acquisition Of Astex Therapeutics 24
Astex Pharmaceuticals Inc – Key Competitors 27
Astex Pharmaceuticals Inc – Key Employees 28
Astex Pharmaceuticals Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Government and Public Interest 30
Oct 26, 2017: Study to test combination therapy for breast cancer 30
Product News 31
Oct 12, 2017: 10 SU2C Catalyst Clinical Trials Launched 31
04/15/2016: Experimental drug guadecitabine found safe in patients with colorectal cancer 33
Clinical Trials 34
Nov 29, 2016: Astex to Showcase Its Next-Generation Hypomethylating Agent ASTX727 at the 2016 Annual Meeting of the American Society of Hematology 34
Nov 29, 2016: Astex to Showcase Its Next-Generation Hypomethylating Agent Being Developed for Treatment of AML/MDS at the 2016 Annual Meeting of the American Society of Hematology 35
Jan 28, 2016: Phase II colorectal cancer clinical trial first to receive support, scientific oversight from Van Andel Research Institute-Stand Up To Cancer Epigenetics Dream Team 36
Other Significant Developments 38
Nov 21, 2016: Astex Joins the Dementia Discovery Fund as a Strategic Investor 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Astex Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Astex Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Astex Pharma Enters into Agreement with Genentech 11
Astex Pharma, Cancer Research Technology And Newcastle University Enter Into Drug Discovery Agreement 12
Astex Pharma, Cancer Research Technology And Institute of Cancer Research Enter Into Epigenetic Drug Discovery Agreement 14
Proteros Biostructures Enters Into Drug Discovery Agreement With SuperGen 16
Astex Pharma Files Registration Statement For Public Offering Of Securities For US$200 Million 17
Tolero Pharma Acquires Drug Development Assets From Astex Pharma 19
Otsuka Pharma Completes Acquisition Of Astex Pharma For US$886 Million 21
Gimv Sells Stake In Astex Therapeutics 23
SuperGen Completes Acquisition Of Astex Therapeutics 24
Astex Pharmaceuticals Inc, Key Competitors 27
Astex Pharmaceuticals Inc, Key Employees 28
Astex Pharmaceuticals Inc, Other Locations 29
Astex Pharmaceuticals Inc, Subsidiaries 29

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Astex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析(Astex Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆